Clinical trial
Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or…
NCT00482599 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00482599 |
|---|---|
| Title | Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED) |
| Official title | A Multicenter, Parallel Group, Comparative Trial Evaluating the Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia, General |
| Intervention type | Drug |
| Interventions | Sugammadex |
| Enrollment | 30 |
| Start date | Jun 1, 2005 |
| Primary completion | Apr 13, 2006 |
| Completion | Apr 13, 2006 |
| First posted | Jun 5, 2007 |
| Last update posted | Jun 16, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: